Switch theme
Sign up to access all valuation multiples
Acer Medical Inc focuses on improving human health and well-being through artificial intelligence. It focuses on applying artificial intelligence and large data to the area of healthcare. Acer Medical is capable of designing, developing, commercializing, as well as implementing AI solutions in medical institutions.
2018
15
LTM Revenue n/a
LTM EBITDA n/a
$53.9M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Acer Medical has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Acer Medical achieved revenue of $1.5M and an EBITDA of -$0.9M.
Acer Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Acer Medical valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $0.8M | $1.5M | XXX | XXX | XXX |
| Gross Profit | $0.2M | $0.4M | XXX | XXX | XXX |
| Gross Margin | 22% | 26% | XXX | XXX | XXX |
| EBITDA | -$1.2M | -$0.9M | XXX | XXX | XXX |
| EBITDA Margin | -145% | -58% | XXX | XXX | XXX |
| Net Profit | -$1.7M | -$1.2M | XXX | XXX | XXX |
| Net Margin | -199% | -76% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Acer Medical's stock price is TWD 131 (or $4).
Acer Medical has current market cap of TWD 2.0B (or $60.0M), and EV of TWD 1.8B (or $53.9M).
See Acer Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $53.9M | $60.0M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Acer Medical has market cap of $60.0M and EV of $53.9M.
Acer Medical's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Acer Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Acer Medical and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $53.9M | XXX | XXX | XXX |
| EV/Revenue | 35.6x | XXX | XXX | XXX |
| EV/EBITDA | -61.6x | XXX | XXX | XXX |
| P/E | -72.6x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -86.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpAcer Medical's NTM/LTM revenue growth is n/a
Acer Medical's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Acer Medical's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Acer Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Acer Medical and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 83% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -58% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -27% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 25% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 45% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 54% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 123% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Beamtree | XXX | XXX | XXX | XXX | XXX | XXX |
| Cogstate | XXX | XXX | XXX | XXX | XXX | XXX |
| Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
| Impedimed | XXX | XXX | XXX | XXX | XXX | XXX |
| Proteomics International | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Acer Medical acquired XXX companies to date.
Last acquisition by Acer Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . Acer Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Acer Medical founded? | Acer Medical was founded in 2018. |
| Where is Acer Medical headquartered? | Acer Medical is headquartered in Taiwan. |
| How many employees does Acer Medical have? | As of today, Acer Medical has 15 employees. |
| Is Acer Medical publicy listed? | Yes, Acer Medical is a public company listed on ROCO. |
| What is the stock symbol of Acer Medical? | Acer Medical trades under 6857 ticker. |
| When did Acer Medical go public? | Acer Medical went public in 2022. |
| Who are competitors of Acer Medical? | Similar companies to Acer Medical include e.g. Beamtree, Cogstate, Echo IQ, Impedimed. |
| What is the current market cap of Acer Medical? | Acer Medical's current market cap is $60.0M |
| What is the current revenue growth of Acer Medical? | Acer Medical revenue growth between 2023 and 2024 was 83%. |
| Is Acer Medical profitable? | Yes, Acer Medical is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
